Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does hematopoietic stem cell transplantation improve patient outcome in juvenile myelomonocytic leukemia?

Nature Clinical Practice Oncology volume 2, pages 294–295 (2005)Cite this article

boxed-textLocatelli F et al. (2005) Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 105: 410–419

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Niemeyer CM et al. (1997) Chronic myelomonocytic leukemia in childhood: a report of 110 cases. Blood 89: 3534–3543

    CAS  PubMed  Google Scholar 

  2. Hasle H et al. (1996) Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia. Leukemia 10: 1269–1273

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Head of the Department of Hematology, AK St. Georg, Hamburg, Germany

    Norbert Schmitz

Authors
  1. Norbert Schmitz
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Norbert Schmitz.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

EWOG-MDS

European Working Group of Myelodysplastic Syndrome in Childhood

EBMT

European Group for Blood and Marrow Transplantation

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schmitz, N. Does hematopoietic stem cell transplantation improve patient outcome in juvenile myelomonocytic leukemia?. Nat Rev Clin Oncol 2, 294–295 (2005). https://doi.org/10.1038/ncponc0179

Download citation

  • Received:

  • Accepted:

  • Issue date:

  • DOI: https://doi.org/10.1038/ncponc0179

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing